|

therapeutic tumor vaccine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Therorna1

Indications

  • HPV 16+ Recurrent or Metastatic Cancer1
  • HNSCC1
  • Cervical Cancer1
  • Cancer1

Other1 trial

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.